A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER TRIAL OF PREGABALIN AS ADJUNCTIVE THERAPY IN PEDIATRIC AND ADULT SUBJECTS WITH PRIMARY GENERALIZED TONIC-CLONIC SEIZURES - PROTOCOL A0081105
Phase: PHASE3
Conditions: Generalized Tonic Clonic Seizures
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

x
DocUUID : e1d43aec-9d74-4848-8354-0bc427f7a589
26 Jul 2019
08:10:057-0400
068f821f-a5ed-4065-b4e3-88d6f1d5beae
090177e1919619bb\Approved\Approved On: 31-Jul-2019 09:24 (GMT)

DocUUID : e1d43aec-9d74-4848-8354-0bc427f7a589
090177e1919619bb\Approved\Approved On: 31-Jul-2019 09:24 (GMT)